NCT05732870Toboroz
OSTEOMICS: Identifying Regulators of Bone Homeostasis
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. aug. 14.
Rövid összefoglaló (regiszter, angolul)
Diseases of bone associated with ageing, including osteoporosis (OP) and osteoarthritis (OA), reduce bone mass, bone strength and joint integrity. Current non-surgical approaches are limited to pharmaceutical agents that are not disease modifying and have poor patient tolerability due to side effect profiles. Developing a fundamental understanding of cellular bone homeostasis, including how key cell types affect tissue health, and offering novel therapeutic targets for prevention of bone disease is therefore essential. This is the focus of OSTEOMICS. A number of factors have been linked to increased risk of bone disease, including genetic predisposition, diet, smoking, ageing, autoimmune disorders and endocrine disorders. In our study, we will recruit patients undergoing elective and non-elective orthopaedic surgery and obtain surgical bone waste for analysis. This will capture a cohort of patients with bone disorders like OP and OA, in addition to patients without overt clinical bone disease. We will study the relationship between the molecular biology of bone cells, bone structure, genetics (DNA) and environmental factors with the aim of identifying and validating novel therapeutic targets. We will leverage modern single cell technologies to understand the diversity of cell types found in bone. These technologies have now led to the characterisation of virtually every tissue in the body, however bone and bone-adjacent tissues are massively underrepresented due to the anatomical location and underlying technical challenges. Early protocols to demineralise bone and perform single cell profiling have now been developed. We will systematically scale up these efforts to observe how genetic variation at the population level leads to alterations in bone structure and quality. Over the next 10 years, we will generate data to comprehensively characterise bone across health and disease, use machine learning to drive analysis, and experimentally validate hypotheses - which will ultimately contribute to developing the next generation of therapeutic agents.
- Állapot (regiszter)
- Toboroz
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 2000 (tervezett)
- Első benyújtás
- 2023. jan. 30.
- Kezdés
- 2023. jan. 12.
- Elsődleges befejezés
- 2027. dec.
- Fő szponzor
- Relation Therapeutics
- Betegségek
- Csontritkulás
- NCT-szám
- NCT05732870
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Tervezett résztvevők: 2000
- 2023. jan. 12. és az elsődleges befejezés (2027. dec.) között
- 8 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- Patients with suspected/established underlying malignancy.
- Patients with suspected/established bloodborne disease
Egyéb
- Patients unable to provide informed consent.
- Patients with suspected/established osteomyelitis.
- Patients who are currently a subject of a clinical trial involving an investigational medicinal product.
Kiket keres a vizsgálat
- Patients with osteoarthritis undergoing total joint arthroplasty, osteotomy or arthrodesis of any joint (including hip, knee, shoulder, wrist, elbow, ankle).
- Patient with fractured neck of femurs undergoing hemiarthroplasty or total hip arthroplasty, or other internal fixation procedure.
- Patients undergoing acute low-velocity or fragility fracture fixation surgery.
- Patients aged between 18-110 years old with capacity to consent.
- Since deteriorating bone health including diseases like osteoporosis are primarily conditions of older age there is no practical upper age-limit. However, study involvement is limited by suitability for surgery which encompasses multiple factors considered on an individual case basis including age, frailty, comorbidities, baseline mobility, renal function and ability to consent (for instance due to dementia or delirium).
- We note that our inclusion criteria is purposefully broad as we aim to deduce trends across a wide range of conditions and backgrounds.
Életkor a regiszterben: 18 év – 110 év · Nem: nők és férfiak
Helyszínek (8)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Luton & Dunstable University Hospital | London | Egyesült Királyság | Fut, nem toboroz |
| King's College Hospital | London | Egyesült Királyság | Toborzás még nem indult |
| West Middlesex University Hospital | London | Egyesült Királyság | Toboroz |
| Fitzrovia Hospital/QASMC | London | Egyesült Királyság | Toboroz |
| Barts Health NHS Trust | London | Egyesült Királyság | Toboroz |
| Chase Farm Hospital | London | Egyesült Királyság | Toboroz |
| Harley Street Specialist Hospital | London | Egyesült Királyság | Fut, nem toboroz |
| Royal National Orthopaedic Hospital NHS Trust | London | Egyesült Királyság | Toborzás még nem indult |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.